Sensei Biotherapeutics (SNSE) Competitors $8.02 +0.19 (+2.43%) Closing price 04:00 PM EasternExtended Trading$8.17 +0.15 (+1.87%) As of 04:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock SNSE vs. ENLV, SLGL, ATNF, ACRV, GBIO, PEPG, XCUR, EGRX, RENB, and HYPDShould you be buying Sensei Biotherapeutics stock or one of its competitors? The main competitors of Sensei Biotherapeutics include Enlivex Therapeutics (ENLV), Sol-Gel Technologies (SLGL), 180 Life Sciences (ATNF), Acrivon Therapeutics (ACRV), Generation Bio (GBIO), PepGen (PEPG), Exicure (XCUR), Eagle Pharmaceuticals (EGRX), Renovaro (RENB), and Hyperion DeFi (HYPD). These companies are all part of the "pharmaceutical products" industry. Sensei Biotherapeutics vs. Its Competitors Enlivex Therapeutics Sol-Gel Technologies 180 Life Sciences Acrivon Therapeutics Generation Bio PepGen Exicure Eagle Pharmaceuticals Renovaro Hyperion DeFi Enlivex Therapeutics (NASDAQ:ENLV) and Sensei Biotherapeutics (NASDAQ:SNSE) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, media sentiment, analyst recommendations, profitability, institutional ownership and valuation. Is ENLV or SNSE more profitable? Enlivex Therapeutics' return on equity of -57.67% beat Sensei Biotherapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Enlivex TherapeuticsN/A -57.67% -50.52% Sensei Biotherapeutics N/A -72.13%-61.35% Which has stronger earnings & valuation, ENLV or SNSE? Enlivex Therapeutics is trading at a lower price-to-earnings ratio than Sensei Biotherapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEnlivex TherapeuticsN/AN/A-$15.01M-$0.66-1.65Sensei BiotherapeuticsN/AN/A-$30.16M-$21.31-0.38 Do institutionals & insiders have more ownership in ENLV or SNSE? 1.0% of Enlivex Therapeutics shares are held by institutional investors. Comparatively, 10.5% of Sensei Biotherapeutics shares are held by institutional investors. 12.3% of Enlivex Therapeutics shares are held by company insiders. Comparatively, 23.2% of Sensei Biotherapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Do analysts prefer ENLV or SNSE? Enlivex Therapeutics presently has a consensus price target of $10.00, indicating a potential upside of 817.43%. Sensei Biotherapeutics has a consensus price target of $55.00, indicating a potential upside of 585.79%. Given Enlivex Therapeutics' higher possible upside, equities research analysts clearly believe Enlivex Therapeutics is more favorable than Sensei Biotherapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Enlivex Therapeutics 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Sensei Biotherapeutics 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33 Does the media favor ENLV or SNSE? In the previous week, Enlivex Therapeutics had 1 more articles in the media than Sensei Biotherapeutics. MarketBeat recorded 2 mentions for Enlivex Therapeutics and 1 mentions for Sensei Biotherapeutics. Sensei Biotherapeutics' average media sentiment score of 1.87 beat Enlivex Therapeutics' score of 0.62 indicating that Sensei Biotherapeutics is being referred to more favorably in the news media. Company Overall Sentiment Enlivex Therapeutics Positive Sensei Biotherapeutics Very Positive Which has more volatility and risk, ENLV or SNSE? Enlivex Therapeutics has a beta of 0.8, suggesting that its stock price is 20% less volatile than the S&P 500. Comparatively, Sensei Biotherapeutics has a beta of 0.26, suggesting that its stock price is 74% less volatile than the S&P 500. SummaryEnlivex Therapeutics beats Sensei Biotherapeutics on 7 of the 13 factors compared between the two stocks. Get Sensei Biotherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SNSE and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SNSE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SNSE vs. The Competition Export to ExcelMetricSensei BiotherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$9.88M$3.10B$5.76B$9.78BDividend YieldN/A2.26%3.95%4.03%P/E Ratio-0.3821.0830.8026.37Price / SalesN/A396.73467.21121.85Price / CashN/A44.4437.7659.36Price / Book0.378.0610.106.62Net Income-$30.16M-$54.08M$3.26B$265.42M7 Day Performance2.62%3.95%3.91%3.58%1 Month Performance14.90%3.02%3.74%0.46%1 Year Performance-35.12%6.84%37.68%19.41% Sensei Biotherapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SNSESensei Biotherapeutics4.6842 of 5 stars$8.02+2.4%$55.00+585.8%-35.6%$9.88MN/A-0.3840Gap UpENLVEnlivex Therapeutics3.2085 of 5 stars$1.25-31.3%$10.00+700.0%-11.5%$43.04MN/A-1.8970Upcoming EarningsGap UpHigh Trading VolumeSLGLSol-Gel Technologies0.7494 of 5 stars$16.10+4.3%N/A+288.4%$43.01M$23.93M-13.0950ATNF180 Life Sciences0.7962 of 5 stars$7.27-4.5%N/A+56.9%$42.52MN/A-0.487Gap DownACRVAcrivon Therapeutics2.9444 of 5 stars$1.39+3.0%$17.57+1,164.1%-85.9%$42.47MN/A-0.6258GBIOGeneration Bio3.4142 of 5 stars$6.63+5.4%$10.67+60.9%-77.9%$42.37M$19.89M-0.61150Positive NewsPEPGPepGen3.3361 of 5 stars$1.30+0.8%$7.67+489.7%-87.1%$42.31MN/A-0.4430Positive NewsXCURExicure1.9958 of 5 stars$6.55-1.5%N/A+1,450.0%$42.01M$500K-1.6950Positive NewsGap UpEGRXEagle PharmaceuticalsN/A$3.20flatN/A-32.1%$41.56M$257.55M0.00100RENBRenovaro1.2383 of 5 stars$0.23-3.3%N/A-67.3%$41.15MN/A-0.3020News CoverageGap UpHYPDHyperion DeFi0.2857 of 5 stars$7.46+3.6%$2.00-73.2%-83.6%$41M$60K-0.1340Positive NewsGap Up Related Companies and Tools Related Companies ENLV Alternatives SLGL Alternatives ATNF Alternatives ACRV Alternatives GBIO Alternatives PEPG Alternatives XCUR Alternatives EGRX Alternatives RENB Alternatives HYPD Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SNSE) was last updated on 8/27/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sensei Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sensei Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access